27.30
-1.07
(-3.77%)
At close: 5:39:30 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 17 | 22 | 22 |
| Avg. Estimate | 3.5B | 3.67B | 14.6B | 15.31B |
| Low Estimate | 3.39B | 3.55B | 14.1B | 14.21B |
| High Estimate | 3.62B | 3.76B | 14.86B | 15.82B |
| Year Ago Sales | 3.68B | 3.7B | 14.54B | 14.6B |
| Sales Growth (year/est) | -4.92% | -0.85% | 0.40% | 4.87% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0HRJ.L | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/2/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/2/2025 |
| Maintains | Susquehanna: Positive to Positive | 3/27/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/27/2025 |
| Downgrade | Loop Capital: Buy to Hold | 2/3/2025 |
| Reiterates | Benchmark: Buy to Buy | 1/27/2025 |